CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
stereotactic body radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00607828
NCT00607828N/ACompleted
CompareCT.gov

Feasibility of Hypofractionated Stereotactic Radiotherapy in Patients With Hepatocellular Carcinoma

University of Nebraska·interventional·Posted Feb 6, 2008·Updated Nov 4, 2024

In Brief

A clinical study evaluating stereotactic body radiation therapy for Liver Cancer. Completed, enrolled 7 participants across 1 site.

Detailed Summary

This is a phase I trial studying the side effects and best dose of stereotactic radiation therapy (SRT) in treating patients with advanced liver cancer. Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 6, 2008
Enrollment StartNov 16, 2007
Primary CompletionFeb 15, 2017
TodayJul 2, 2026
Enrollment to primary: 9.2 yearsPosted 18.4 years ago

Interventions

stereotactic body radiation therapyradiation

Undergo radiotherapy